4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-023033
Chairman and CEO bought 30,800 shares at an average $1.26 ($38,784)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-04-01 | Purchase | +22,500 | $1.27 | $28,575 | 10,553,743 | D |
| Niihara Yutaka Chairman and CEO | 2020-04-02 | Purchase | +8,300 | $1.23 | $10,209 | 10,562,043 | D |
| Open-market purchases · 30,800 sh · avg $1.26 · $38,784 | |||||||
Loading xslF345X03/doc4.xml…